Annual Long Term Debt
$0.00
-$4300.00-100.00%
30 September 2023
Summary:
Outlook Therapeutics annual long term debt is currently $0.00, with the most recent change of -$4300.00 (-100.00%) on 30 September 2023. During the last 3 years, it has fallen by -$10.93 million (-100.00%). OTLK annual long term debt is now -100.00% below its all-time high of $13.41 million, reached on 30 September 2017.OTLK Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$260.40 K
0.00%
30 June 2024
Summary:
Outlook Therapeutics quarterly long term debt is currently $260.40 thousandOver the past year, it has increased by +$260.40 thousand (+100.00%). OTLK quarterly long term debt is now -99.18% below its all-time high of $31.82 million, reached on 31 December 2022.OTLK Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OTLK Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +100.0% |
| 3 y3 years | -100.0% | -97.6% |
| 5 y5 years | -100.0% | -92.4% |
OTLK Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | -99.2% | ||
| 5 y | 5 years | -100.0% | -99.2% | ||
| alltime | all time | -100.0% | -99.2% |
Outlook Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $260.40 K(>+9900.0%) |
| Sept 2023 | $0.00(-100.0%) | $0.00(0.0%) |
| June 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(-100.0%) |
| Dec 2022 | - | $31.82 M(>+9900.0%) |
| Sept 2022 | $4300.00(-100.0%) | $4300.00(-41.1%) |
| June 2022 | - | $7300.00(-49.0%) |
| Mar 2022 | - | $14.30 K(-99.9%) |
| Dec 2021 | - | $9.63 M(-11.9%) |
| Sept 2021 | $10.93 M(+1054.4%) | $10.93 M(>+9900.0%) |
| June 2021 | - | $59.90 K(-62.1%) |
| Mar 2021 | - | $157.90 K(-98.5%) |
| Dec 2020 | - | $10.69 M(+1029.6%) |
| Sept 2020 | $946.70 K(-72.3%) | $946.70 K(+47.3%) |
| June 2020 | - | $642.50 K(-81.5%) |
| Mar 2020 | - | $3.47 M(-1.6%) |
| Dec 2019 | - | $3.52 M(+3.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | $3.42 M(-3.8%) | $3.42 M(+0.2%) |
| June 2019 | - | $3.41 M(-1.6%) |
| Mar 2019 | - | $3.46 M(-0.7%) |
| Dec 2018 | - | $3.49 M(-1.8%) |
| Sept 2018 | $3.55 M(-73.5%) | $3.55 M(-1.9%) |
| June 2018 | - | $3.62 M(-0.5%) |
| Mar 2018 | - | $3.64 M(+1856.2%) |
| Dec 2017 | - | $186.00 K(-98.6%) |
| Sept 2017 | $13.41 M(+425.0%) | $13.41 M(+6618.9%) |
| June 2017 | - | $199.60 K(-9.7%) |
| Mar 2017 | - | $221.10 K(-27.3%) |
| Dec 2016 | - | $304.30 K(-88.1%) |
| Sept 2016 | $2.55 M(-58.4%) | $2.55 M(-13.0%) |
| June 2016 | - | $2.93 M(-12.6%) |
| Mar 2016 | - | $3.36 M(-10.0%) |
| Dec 2015 | - | $3.73 M(-39.2%) |
| Sept 2015 | $6.14 M(0.0%) | $6.14 M |
| Sept 2014 | $6.14 M | - |
FAQ
- What is Outlook Therapeutics annual long term debt?
- What is the all time high annual long term debt for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly long term debt year-on-year change?
What is Outlook Therapeutics annual long term debt?
The current annual long term debt of OTLK is $0.00
What is the all time high annual long term debt for Outlook Therapeutics?
Outlook Therapeutics all-time high annual long term debt is $13.41 M
What is Outlook Therapeutics quarterly long term debt?
The current quarterly long term debt of OTLK is $260.40 K
What is the all time high quarterly long term debt for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly long term debt is $31.82 M
What is Outlook Therapeutics quarterly long term debt year-on-year change?
Over the past year, OTLK quarterly long term debt has changed by +$260.40 K (+100.00%)